Dehaier Announces Upcoming Road Show in February Print E-mail
By GLOBE NEWSWIRE   
Thursday, 16 January 2014 03:00

BEIJING--Dehaier Medical Systems Ltd. (Nasdaq:DHRM) ("Dehaier" or the "Company"), an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced that company will conduct a non-deal road show, with meetings in Silicon Valley and New York for one week in February 2014.

During the road show, management will present updates to the Company's business and line of sleep apnea products and will discuss the Company's growth strategy.

Dehaier's CEO Mr. Chen Ping stated, "2014 will be crucial for Dehaier as we start to invest a large amount of capital and

effort in R&D, product licensure and

Error. Page cannot be displayed. Please contact your service provider for more details. (26)

registration and
market expansion. With our increasingly robust sleep apnea product line, Dehaier will continue to expand its footprint in the Chinese market this year. During our February trip, we look forward to the opportunity to share these and other developments with investors and others who follow our Company."

About Dehaier Medical Systems Ltd.

Dehaier is an emerging leader in the development, assembly, marketing and sale of medical products, including respiratory and oxygen homecare medical products. The company develops and assembles its own branded medical devices and homecare medical products from third-party components. The company also distributes products designed and manufactured by other companies, including medical devices from IMD (Italy), Welch Allyn (USA), HEYER (Germany), Timesco (UK), eVent Medical (US) and JMS (Japan). Dehaier's technology is based on six patents, ten software copyrights and proprietary technology. More information may be found at http://www.dehaier.com.cn

Forward-looking Statements

This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, fulfillment of bids and contracts, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in reports filed by the company with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.

CONTACT: Dehaier Medical Systems Limited          Surie Liu          +86 10-5166-0080          lius@dehaier.com.cn                    Dehaier Medical Systems Limited          Tina He          +86 10-5166-0080          hexw@dehaier.com.cn



BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!
 

Newsletter

BMR:1